(Q46150270)

19 December 2017

title

Predictors of extracapsular extension and positive margins in African American and white men. (English)

1 reference

19 December 2017

author name string

Edmond L Paquette

1

1 reference

19 December 2017

Roger R Connelly

2

1 reference

19 December 2017

Leon Sun

3

1 reference

19 December 2017

Laurence R Paquette

4

1 reference

19 December 2017

Judd W Moul

5

1 reference

19 December 2017

language of work or name

1 reference

1 January 2003

1 reference

19 December 2017

published in

Urologic Oncology

1 reference

19 December 2017

volume

21

1 reference

19 December 2017

issue

1

1 reference

19 December 2017

page(s)

33-38

1 reference

19 December 2017

Racial differences in adenocarcinoma of the prostate in North American men.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

Effect of age and race on the survival of men with prostate cancer in the Metropolitan Detroit tricounty area, 1973 to 1987

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

Race is not an independent predictor of positive surgical margins after radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

The predictive value of race as a clinical prognostic factor among patients with clinically localized prostate cancer: a multivariate analysis of positive surgical margins

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

Statistical modeling using preoperative prognostic variables in predicting extracapsular extension and progression after radical prostatectomy for prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

Knowledge, beliefs, and prior screening behavior among blacks and whites reporting for prostate cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

A national survey of attitudes regarding participation in prostate carcinoma testing.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

Declining rates of extracapsular extension after radical prostatectomy: evidence for continued stage migration

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

Incidence and significance of positive margins in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

Prognostic significance of positive surgical margins in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

Radical retropubic prostatectomy: time trends, morbidity and mortality in Japan.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

Improvements in pathologic staging for African-American men undergoing radical retropubic prostatectomy during the prostate specific antigen era: implications for screening a high-risk group for prostate carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

Surgical control of clinically localized prostate carcinoma is equivalent in African-American and white males

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

Racial differences in prostate cancer growth: apoptosis and cell proliferation in Caucasian and African-American patients

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

The CAG repeat within the androgen receptor gene and its relationship to prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

Re: Prostate cancer and the androgen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable disease

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

Ability of preoperative serum prostate-specific antigen value to predict pathologic stage and DNA ploidy. Influence of clinical stage and tumor grade

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

Combining prostate specific antigen with cancer and gland volume to predict more reliably pathological stage: the influence of prostate specific antigen cancer density

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

Preoperative serum prostate-specific antigen and gleason grade as predictors of pathologic stage in clinically organ confined prostate cancer: Implications for the choice of primary treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

Prediction of capsular perforation and seminal vesicle invasion in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

Racial differences in prostate-specific antigen levels and prostate-specific antigen densities in patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

Prostatic adenocarcinoma: reproducibility and correlation with clinical stages of four grading systems.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

Histologic grading of prostate cancer: a perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900203-X

7 January 2021

10.1016/S1078-1439(02)00203-X

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017